3-Thiosymbescaline
Pharmaceutical compound
From Wikipedia, the free encyclopedia
3-Thiosymbescaline (3-TSB), also known as 3-ethylthio-4-methoxy-5-ethoxyphenethylamine, is a chemical compound of the phenethylamine and scaline families related to mescaline.[1][2][3][4] It is the analogue of symbescaline in which the ethoxy group at the 3 position has been replaced with an ethylthio group.[1][2][3][4] The compound is one of two possible thiosymbescaline (TSB) positional isomers, the other being 4-thiosymbescaline (4-TSB).[1][2][3][4]
- None
| Clinical data | |
|---|---|
| Other names | 3-TSB; 3-Ethylthio-4-methoxy-5-ethoxyphenethylamine; 3-EtS-4-MeO-5-EtO-PEA |
| Routes of administration | Oral[1] |
| ATC code |
|
| Pharmacokinetic data | |
| Duration of action | Unknown[1] |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| Chemical and physical data | |
| Formula | C13H21NO2S |
| Molar mass | 255.38 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
In his book PiHKAL (Phenethylamines I Have Known and Loved) and other publications, Alexander Shulgin lists 3-TSB's dose as greater than 200 mg orally and its duration as unknown.[1][2][3] The compound produced no effects whatsoever at a dose of up to 200 mg orally.[1]
The chemical synthesis of 3-TSB has been described.[1][4]
3-TSB was first described in the scientific literature by Shulgin and Peyton Jacob III in 1984.[4] Subsequently, it was described in greater detail by Shulgin in PiHKAL in 1991.[1]